• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

ADNI4 数字研究:一种用于招募、筛选和评估 AD 临床研究参与者的新方法。

The ADNI4 Digital Study: A novel approach to recruitment, screening, and assessment of participants for AD clinical research.

机构信息

Northern California Institute for Research and Education (NCIRE), San Francisco, California, USA.

VA Advanced Imaging Research Center, Department of Veterans Affairs Medical Center, San Francisco, California, USA.

出版信息

Alzheimers Dement. 2024 Oct;20(10):7232-7247. doi: 10.1002/alz.14234. Epub 2024 Sep 1.

DOI:10.1002/alz.14234
PMID:39219153
原文链接:
https://pmc.ncbi.nlm.nih.gov/articles/PMC11485063/
Abstract

INTRODUCTION

We evaluated preliminary feasibility of a digital, culturally-informed approach to recruit and screen participants for the Alzheimer's Disease Neuroimaging Initiative (ADNI4).

METHODS

Participants were recruited using digital advertising and completed digital surveys (e.g., demographics, medical exclusion criteria, 12-item Everyday Cognition Scale [ECog-12]), Novoic Storyteller speech-based cognitive test). Completion rates and assessment performance were compared between underrepresented populations (URPs: individuals from ethnoculturally minoritized or low education backgrounds) and non-URPs.

RESULTS

Of 3099 participants who provided contact information, 654 enrolled in the cohort, and 595 completed at least one assessment. Two hundred forty-seven participants were from URPs. Of those enrolled, 465 met ADNI4 inclusion criteria and 237 evidenced possible cognitive impairment from ECog-12 or Storyteller performance. URPs had lower ECog and Storyteller completion rates. Scores varied by ethnocultural group and educational level.

DISCUSSION

Preliminary results demonstrate digital recruitment and screening assessment of an older diverse cohort, including those with possible cognitive impairment, are feasible. Improving engagement and achieving educational diversity are key challenges.

HIGHLIGHTS

A total of 654 participants enrolled in a digital cohort to facilitate ADNI4 recruitment. Culturally-informed digital ads aided enrollment of underrepresented populations. From those enrolled, 42% were from underrepresented ethnocultural and educational groups. Digital screening tools indicate > 50% of participants likely cognitively impaired. Completion rates and assessment performance vary by ethnocultural group and education.

摘要

简介

我们评估了一种数字化、文化知情的方法招募和筛选阿尔茨海默病神经影像学倡议(ADNI4)参与者的初步可行性。

方法

参与者通过数字广告招募,并完成数字调查(例如,人口统计学、医学排除标准、12 项日常认知量表 [ECog-12])、Novoic Storyteller 基于语音的认知测试)。在代表性不足的人群(URP:来自少数民族或教育程度较低的群体)和非 URP 人群之间比较了完成率和评估表现。

结果

在提供联系信息的 3099 名参与者中,有 654 名参加了该队列,有 595 名完成了至少一项评估。247 名参与者来自 URP。在注册的参与者中,有 465 人符合 ADNI4 纳入标准,有 237 人根据 ECog-12 或 Storyteller 表现表现出可能的认知障碍。URP 的 ECog 和 Storyteller 完成率较低。分数因民族文化群体和教育水平而异。

讨论

初步结果表明,对年龄较大的多样化队列进行数字化招募和筛选评估是可行的,包括可能有认知障碍的人群。提高参与度和实现教育多样性是关键挑战。

亮点

共有 654 名参与者注册了一个数字队列,以促进 ADNI4 的招募。文化知情的数字广告有助于招募代表性不足的人群。在注册的参与者中,有 42%来自代表性不足的民族文化和教育群体。数字筛选工具表明,超过 50%的参与者可能有认知障碍。完成率和评估表现因民族文化群体和教育水平而异。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f66c/11485063/8b9c366d6c18/ALZ-20-7232-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f66c/11485063/182c1221f651/ALZ-20-7232-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f66c/11485063/88d24dc998d3/ALZ-20-7232-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f66c/11485063/88e089f51ab9/ALZ-20-7232-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f66c/11485063/8b9c366d6c18/ALZ-20-7232-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f66c/11485063/182c1221f651/ALZ-20-7232-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f66c/11485063/88d24dc998d3/ALZ-20-7232-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f66c/11485063/88e089f51ab9/ALZ-20-7232-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f66c/11485063/8b9c366d6c18/ALZ-20-7232-g003.jpg

相似文献

1
The ADNI4 Digital Study: A novel approach to recruitment, screening, and assessment of participants for AD clinical research.ADNI4 数字研究:一种用于招募、筛选和评估 AD 临床研究参与者的新方法。
Alzheimers Dement. 2024 Oct;20(10):7232-7247. doi: 10.1002/alz.14234. Epub 2024 Sep 1.
2
The Community Engaged Digital Alzheimer's Research (CEDAR) Study: A Digital Intervention to Increase Research Participation of Black American Participants in the Brain Health Registry.社区参与式数字阿尔茨海默病研究(CEDAR):一项数字干预措施,旨在增加美国黑人参与者在大脑健康注册中心的研究参与度。
J Prev Alzheimers Dis. 2023;10(4):847-856. doi: 10.14283/jpad.2023.32.
3
The AlzMatch Pilot Study - Feasibility of Remote Blood Collection of Plasma Biomarkers for Preclinical Alzheimer's Disease Trials.阿尔茨海默病匹配先导研究 - 远程采集用于临床前阿尔茨海默病试验的血浆生物标志物的可行性。
J Prev Alzheimers Dis. 2024;11(5):1435-1444. doi: 10.14283/jpad.2024.101.
4
Increasing participant diversity in AD research: Plans for digital screening, blood testing, and a community-engaged approach in the Alzheimer's Disease Neuroimaging Initiative 4.增加 AD 研究中的参与者多样性:在阿尔茨海默病神经影像学倡议 4 中进行数字筛查、血液检测和社区参与方法的计划。
Alzheimers Dement. 2023 Jan;19(1):307-317. doi: 10.1002/alz.12797. Epub 2022 Oct 9.
5
¹⁸F-FDG PET for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).¹⁸F - 氟代脱氧葡萄糖正电子发射断层显像(¹⁸F - FDG PET)用于轻度认知障碍(MCI)患者中阿尔茨海默病性痴呆及其他痴呆的早期诊断。
Cochrane Database Syst Rev. 2015 Jan 28;1(1):CD010632. doi: 10.1002/14651858.CD010632.pub2.
6
Associations of circulating saturated long-chain fatty acids with risk of mild cognitive impairment and Alzheimer's disease in the Alzheimer's Disease Neuroimaging Initiative (ADNI) cohort.循环饱和长链脂肪酸与阿尔茨海默病神经影像学倡议 (ADNI) 队列中轻度认知障碍和阿尔茨海默病风险的关联。
EBioMedicine. 2023 Nov;97:104818. doi: 10.1016/j.ebiom.2023.104818. Epub 2023 Oct 2.
7
Storyteller in ADNI4: Application of an early Alzheimer's disease screening tool using brief, remote, and speech-based testing.ADNI4 中的故事讲述者:使用简短、远程和基于语音的测试进行早期阿尔茨海默病筛查工具的应用。
Alzheimers Dement. 2024 Oct;20(10):7248-7262. doi: 10.1002/alz.14206. Epub 2024 Sep 5.
8
Galantamine for dementia due to Alzheimer's disease and mild cognitive impairment.加兰他敏治疗阿尔茨海默病所致痴呆和轻度认知障碍。
Cochrane Database Syst Rev. 2024 Nov 5;11(11):CD001747. doi: 10.1002/14651858.CD001747.pub4.
9
Understanding Barriers and Facilitators to Signing Up for a Mobile-Responsive Registry to Recruit Healthy Volunteers and Members of Underrepresented Communities for Alzheimer's Disease Prevention Studies.了解健康志愿者和代表性不足社区成员报名参加移动响应注册以参与阿尔茨海默病预防研究的障碍和促进因素。
J Prev Alzheimers Dis. 2023;10(4):865-874. doi: 10.14283/jpad.2023.67.
10
CSF tau and the CSF tau/ABeta ratio for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).脑脊液tau蛋白及脑脊液tau蛋白与β淀粉样蛋白比值在轻度认知障碍(MCI)患者中用于诊断阿尔茨海默病性痴呆及其他痴呆。
Cochrane Database Syst Rev. 2017 Mar 22;3(3):CD010803. doi: 10.1002/14651858.CD010803.pub2.

引用本文的文献

1
A scoping review of remote and unsupervised digital cognitive assessments in preclinical Alzheimer's disease.对临床前阿尔茨海默病远程和无监督数字认知评估的范围综述。
NPJ Digit Med. 2025 May 10;8(1):266. doi: 10.1038/s41746-025-01583-5.
2
Overview of Alzheimer's Disease Neuroimaging Initiative and future clinical trials.阿尔茨海默病神经影像学计划概述及未来临床试验
Alzheimers Dement. 2025 Jan;21(1):e14321. doi: 10.1002/alz.14321. Epub 2024 Dec 22.
3
The Alzheimer's Disease Neuroimaging Initiative-4 (ADNI-4) Engagement Core: A culturally informed, community-engaged research (CI-CER) model to advance brain health equity.

本文引用的文献

1
Usability of a Web-Based Registry for Preclinical Alzheimer's Disease: Implications from a Cross-Sectional Online Survey.基于网络的阿尔茨海默病临床前登记系统的可用性:来自横断面在线调查的启示。
J Prev Alzheimers Dis. 2024;11(3):661-671. doi: 10.14283/jpad.2024.48.
2
The All of Us Research Program is an opportunity to enhance the diversity of US biomedical research.“我们所有人”研究计划是一个增强美国生物医学研究多样性的契机。
Nat Med. 2024 Feb;30(2):330-333. doi: 10.1038/s41591-023-02744-3.
3
Alzheimer's disease drug development pipeline: 2023.
阿尔茨海默病神经影像学计划-4(ADNI-4)参与核心:一种促进大脑健康公平性的文化知情、社区参与研究(CI-CER)模式。
Alzheimers Dement. 2024 Dec;20(12):8279-8293. doi: 10.1002/alz.14242. Epub 2024 Oct 23.
4
A scoping review of remote and unsupervised digital cognitive assessments in preclinical Alzheimer's disease.临床前阿尔茨海默病远程和非监督式数字认知评估的范围综述
medRxiv. 2025 Mar 25:2024.09.25.24314349. doi: 10.1101/2024.09.25.24314349.
5
Contributions of the ADNI Biostatistics Core.ADNI 生物统计学核心的贡献。
Alzheimers Dement. 2024 Oct;20(10):7331-7339. doi: 10.1002/alz.14159. Epub 2024 Aug 14.
2023年阿尔茨海默病药物研发进展
Alzheimers Dement (N Y). 2023 May 25;9(2):e12385. doi: 10.1002/trc2.12385. eCollection 2023 Apr-Jun.
4
Brain health registry updates: An online longitudinal neuroscience platform.脑健康登记更新:一个在线纵向神经科学平台。
Alzheimers Dement. 2023 Nov;19(11):4935-4951. doi: 10.1002/alz.13077. Epub 2023 Apr 18.
5
2023 Alzheimer's disease facts and figures.2023 年阿尔茨海默病事实和数据。
Alzheimers Dement. 2023 Apr;19(4):1598-1695. doi: 10.1002/alz.13016. Epub 2023 Mar 14.
6
Leveraging speech and artificial intelligence to screen for early Alzheimer's disease and amyloid beta positivity.利用语音和人工智能筛查早期阿尔茨海默病及β-淀粉样蛋白阳性情况。
Brain Commun. 2022 Oct 14;4(5):fcac231. doi: 10.1093/braincomms/fcac231. eCollection 2022.
7
Improving generalizability and study design of Alzheimer's disease cohort studies in the United States by including under-represented populations.通过纳入代表性不足的人群,提高美国阿尔茨海默病队列研究的泛化能力和研究设计。
Alzheimers Dement. 2023 Apr;19(4):1549-1557. doi: 10.1002/alz.12823. Epub 2022 Nov 13.
8
Increasing participant diversity in AD research: Plans for digital screening, blood testing, and a community-engaged approach in the Alzheimer's Disease Neuroimaging Initiative 4.增加 AD 研究中的参与者多样性:在阿尔茨海默病神经影像学倡议 4 中进行数字筛查、血液检测和社区参与方法的计划。
Alzheimers Dement. 2023 Jan;19(1):307-317. doi: 10.1002/alz.12797. Epub 2022 Oct 9.
9
Validation of a Remote and Fully Automated Story Recall Task to Assess for Early Cognitive Impairment in Older Adults: Longitudinal Case-Control Observational Study.一项用于评估老年人早期认知障碍的远程全自动故事回忆任务的验证:纵向病例对照观察研究
JMIR Aging. 2022 Sep 30;5(3):e37090. doi: 10.2196/37090.
10
Recommendations to address key recruitment challenges of Alzheimer's disease clinical trials.解决阿尔茨海默病临床试验关键招募挑战的建议。
Alzheimers Dement. 2023 Feb;19(2):696-707. doi: 10.1002/alz.12737. Epub 2022 Aug 10.